Academic Engagement Initiative

The primary aim of Charles River’s Academic Engagement Initiative is to help academic groups to identify the best new therapeutic strategy ideas and to provide an effective and user-friendly mechanism to progress these ideas towards high-quality chemical matter.

If you are seeking grant funding, you can benefit from our expert support and insight in identifying funding sources and preparing grant applications. We have had considerable success in obtaining grant funding with our partners and in achieving their ultimate goal—preclinical candidate nomination.

Charles River does not seek to retain any intellectual property relating to the project; this will remain with the originating institution.

Use our know-how to maximize your chance of obtaining a grant. We will:

  • Work with you to generate your preliminary funding application for grants such as those from the Wellcome Trust, Horizon 2020, or Biomedical Catalyst grants, including Confidence in Concept (MRC) and Developmental Pathway Funding Scheme (DPFS)
  • Draft all of the required drug discovery aspects of the application
  • Attend assessment presentations and meetings
  • Help you to secure valuable multi-year funding
  • Clinical candidate (UE2343) identified in collaboration with the University of Edinburgh. Subsequently licensed to Actinogen. Phase II studies to commence in 2016
  • Five ongoing Wellcome Trust Seeding Drug Discovery (SDD) grant funded programs, including one with a North American university
  • Four ongoing Wellcome Trust Pathfinder award funded projects

You may also be interested in...

Computer-aided Drug Design (CADD)

Our CADD capabilities are available as part of integrated hit identification, hit expansion, hit-to-lead and lead optimization programs or as a stand-alone offering.

In Vitro ADME Screening

We offer a flexible approach to our ADME services, with multiple formats available for many of our in vitro assays to suit the different stages of the drug discovery pipeline.

The Best of Both Worlds

This blog talks about how CROs are helping university groups translate their ideas into drug candidates.